Vivimed Labs Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹15.99 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 22.42 per cent from ₹20.61 crore. This corresponds to a year-on-year *(YoY) decline of 56.20 per cent.
Operating Profit
Operating Profit stands at ₹-10.92 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1,037.50 per cent from ₹-0.96 crore. This corresponds to a year-on-year *(YoY) decline of 1,130.19 per cent.
PBDT
PBDT stands at ₹-11.92 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 396.67 per cent from ₹-2.40 crore. This corresponds to a year-on-year *(YoY) decline of 1,962.50 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-16.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 126.71 per cent from ₹-7.30 crore. This corresponds to a year-on-year *(YoY) decline of 176.76 per cent.
Net Profit
Net Profit stands at ₹-16.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 126.71 per cent from ₹-7.30 crore. This represents a 176.76 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Vivimed Labs Ltd Earnings
- YOY
- QOQ
Vivimed Labs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Vivimed Labs Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Vivimed Labs Ltd Financial Reports
Vivimed Labs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Vivimed Labs. | 2.64% | -0.45% | -2.22% | -8.83% | -75.07% | -75.07% |
| Vivo Bio Tech | 1.77% | -0.47% | -1.96% | 4.59% | -10.49% | -28.80% |
| Kabra Drugs | -3.25% | -0.04% | -1.57% | -19.34% | -22.07% | 109.80% |
| Biofil Chemicals | -3.14% | 12.68% | 5.82% | 15.49% | -6.52% | -28.04% |
| Shelter Pharma | 6.90% | 4.70% | 5.56% | -3.14% | -20.74% | -21.63% |
| Phaarmasia | 0.00% | -4.19% | -21.10% | -5.86% | 17.79% | 185.48% |
| Vista Pharma. | 7.38% | 18.16% | 8.60% | 48.10% | -0.12% | -18.89% |
Company Info
Company Information
Chairman & Wholetime Director : V Manohar Rao
Executive Director & MD : Santosh Varalwar
Independent Non Exe. Director : Sandeep Varalwar
Independent Non Exe. Director : Aparna Bidarkar
Independent Non Exe. Director : Subbarathnamma PalepU
Independent Non Exe. Director : Jarugula Siva Prasad
Company Sec. & Compli. Officer : Yugandhar Kopparthi